Wealth Enhancement Advisory Services’s BioCardia BCDA Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$19.6K	Hold	18,500	–	–	﹤0.01%	4131
2026 Q2	$16.9K	Buy	+18,500	New	+$19.5K	﹤0.01%	4053
2026 Q1	–	Sell	-20,000	Closed	-$25.4K	–	3597
2025 Q4	$25.4K	Buy	20,000 +3,000	+18%	+$4.08K	﹤0.01%	3571
2025 Q3	$22.4K	Buy	+17,000	New	+$33.2K	﹤0.01%	3501

Other funds holding BCDA

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

Wealth Enhancement Advisory Services's BCDA Position: Q3 2026 in Review

Wealth Enhancement Advisory Services held its BioCardia (BCDA) position steady in Q3 2026 at 18,500 shares worth $19.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4131.

Wealth Enhancement Advisory Services first reported a position in BCDA in Q3 2025 and has held it in 4 quarters since. The position peaked at $25.4K in Q4 2025. 3 funds tracked by Wall St. Rank hold BCDA as of Q3 2026.

Wealth Enhancement Advisory Services held 18,500 shares of BioCardia worth $19.6K as of Q3 2026.
Wealth Enhancement Advisory Services left its BioCardia share count unchanged in Q3 2026.
BioCardia made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #4131 holding.
Wealth Enhancement Advisory Services first reported a position in BioCardia in Q3 2025 and has held it in 4 quarters since.
Wealth Enhancement Advisory Services's BioCardia position peaked at $25.4K in Q4 2025.
3 funds tracked by Wall St. Rank held BioCardia as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.